Brief: Dermapharm Expects Consolidated Revenue Of Between Eur 1.1 Bln And Eur 1.2 Bln In 2025

Dermapharm Holding SE

14/03/2025 06:35

March 14 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE:

DERMAPHARM FY EBITDA MARGIN 26.2%

DERMAPHARM FY ADJUSTED EBITDA EUR 315.6 MILLION

DERMAPHARM FY ADJUSTED EBITDA MARGIN 26.7%

DERMAPHARM FY EBITDA EUR 308.9 MILLION

DERMAPHARM FY REVENUE EUR 1,180.8 MILLION VERSUS. IBES ESTIMATE EUR 1,188 MILLION

TO PROPOSE A DIVIDEND OF 90 CENTS PER SHARE FOR PAST FINANCIAL YEAR TO ANNUAL GENERAL MEETING

EXPECTS CONSOLIDATED REVENUE OF BETWEEN EUR 1,160 MILLION AND EUR 1,200 MILLION IN CURRENT FINANCIAL YEAR.

ADJUSTED EBITDA IS EXPECTED TO GROW TO BETWEEN EUR 322 MILLION AND EUR 332 MILLION

Source text: ID:nEQ2frlcSa

Further company coverage: DMPG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))